BIS Research Study Highlights the Global Non-Invasive Prenatal Testing (NIPT) Market to Reach $12.61 billion by 2031

BIS Research Study Highlights the Global Non-Invasive Prenatal Testing (NIPT) Market to Reach $12.61 billion by 2031

PR Newswire

FREMONT, Calif., Jan. 6, 2022

FREMONT, Calif., Jan. 6, 2022 /PRNewswire/ -- The global non-invasive prenatal testing market is projected to reach $12.61 billion in terms of revenue by 2031 at a CAGR of 15.79%, reveals the premium market intelligence study by BIS Research. The study also highlights that the NIPT market is set to generate 28.94 million units in terms of volume while witnessing a CAGR of 21.35% during the forecast period 2021-2031. 


The life science industry is witnessing significant growth of NIPT tests developed using NGS technology. Several biotechnology companies are now indulging in the research and development of such NGS-based NIPT products. BIS Research healthcare experts have found the global NIPT market to be one of the most rapidly evolving markets amongst the other prenatal testing industries.

The detailed study is a compilation of 16 Market Data Tables and 269 Figures spread through 301 Pages and in-depth TOC on "Global Non-Invasive Prenatal Testing Market – Analysis and Forecast, 2021-2031".

USP of the Report

Analyst's Take on the Market:

According to Nitish Kumar, Lead Analyst at BIS Research, "North America is the leading contributor to the global NIPT market. The contribution of North America to the global NIPT market was valued at approximately 48.00% and 42.10% in terms of revenue and volume, respectively, in 2020. Application areas such as the IONA test and trisomy detection application are expected to progress at significant rates. Further, the significant development in the reimbursement policies in the region is consequentially fueling the growth of the North America NIPT market. However, Asia-Pacific is expected to grow at an impressive CAGR of 17.34% and 22.42% in terms of revenue and volume respectively during the forecast period between 2021-2031"

View the Report from BIS Research at Global Non-Invasive Prenatal Testing Market

Key Companies Operating in the Market and Competition Landscape

This report is a meticulous compilation of research on more than 15 players in the market ecosystem and profiles 15 companies, including several key players, namely Agilent Technologies, Inc., BGI, CENTOGENE N.V., Eurofins Scientific, F. Hoffmann-La Roche Ltd., Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., PerkinElmer Inc., Quest Diagnostics Incorporated, Annoroad Gene Technology, MedGenome Inc., Myriad Genetics, Inc., Next Biosciences, and Yourgene Health PLC.

The study also offers strategic recommendations that can help organizations in tracking various products, trends, and technologies that are changing the dynamics of the market. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.

Who Should Buy this Report?

Request for a Sample:

Key Questions Answered in the Report:

BIS Research Related Market Studies:

Global Carrier Screening Market – Analysis and Forecast, 2021-2031

Global In-Vitro Fertilization Market – Analysis and Forecast, 2020-2030

About BIS Research: 

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends which can disrupt the market dynamics in the near future. We publish more than 200 market intelligence studies annually that focus on several deep technology verticals. 

Our strategic market analysis emphasizes on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management. 

BIS Research offers syndicate as well as custom studies and expert consultations to firms, providing them specific and actionable insights on novel technology markets, business models, and competitive landscape. 

BIS Healthcare vertical offers intelligence in the healthcare technology market for Medical Devices, Digital Health, Life Sciences, Robotics and Imaging, Information Technology, Precision Medicine, and other emerging healthcare technologies, covering the entire industry spectrum. In the past 5 years, BIS Healthcare has published more than 50 reports under the precision medicine banner. Additionally, BIS Research has been nominating Top 25 Voices in Precision Medicine on its Insight Monk platform for the past two years successfully.  


Bhavya Banga
BIS Research Inc.
FREMONT CA 94538-1686
Visit our Blog @
Connect with us on LinkedIn @ 
Connect with us on Twitter@ 


Voltar noticias em Inglês